Please login to the form below

Not currently logged in
Email:
Password:

Novasep appoints board chairman

CEO Michel Spagnol takes on dual role

Novasep Michel Spagnol Novasep has named CEO Michel Spagnol as its chairman of the supervisory board.

Spagnol has led the executive team at the French manufacturing firm since June 2013, and will now add supervisory leadership to his role following the departure of former chairman Roger-Marc Nicoud.

During his short time as CEO, Spagnol has already instigated several changes, including the appointments of a new chief financial officer and presidents of both the synthesis business and industrial biotech units.

Prior to joining Novasep, Spagnol was president and chief technology officer at Shasun having previously been with Rhodia.

“Novasep is evolving, with a strong leadership team and a new logo 'Passion and smart processes', representing our refocused strategy,” said Spagnol. “We will continue building on our strong foundations while developing on the excellence of our services and technologies. I wish Roger-Marc continued success in his new endeavours."

5th March 2014

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Novasecta

We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance...

Latest intelligence

CBC
Building Europe’s next breakthrough biotechs
Start Codon's Daniel Rooke on fostering biotech success in Cambridge, UK...
Tactful screening & participant sensitivity
Screening participants can involve asking personal questions that could be perceived as intrusive. Here CMR explores the implications of such lines of questioning....
Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...

Infographics